Development and in vitro evaluation of nimodipine transdermal formulations using factorial design

Pharmaceutical Development and Technology

Volumn 3, Issue 4, 1998, Pages 517-525

  Giannakou, Stergiana A ^a   Dallas, Paraskevas P ^a   Rekkas, Dimitrios M ^a   Choulis, Nikolaos H ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Factorial design; Gels; Nimodipine; Penetration enhancers; Transdermal

Indexed keywords

ALKANOIC ACID; ALKANOL; CINEOLE; ESSENTIAL OIL; ESTER; GELLING AGENT; MENTHOL; MYRISTYL ALCOHOL; NIMODIPINE; OCTANOIC ACID; OLEIC ACID;

ARTICLE; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SKIN; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031739552     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459809028634     Document Type: Article

References (29)

1. M. S. Langley and E. M. Sorkin, Nimodipine, a review, Drugs, 37, 669-699 (1989).
2. S. Kazda, Pharmacology of nimodipine, a calcium antagonist with preferential cerebrovascular activity, Neurochirurgia, 28, 70-73 (1985).
3. L. M. Auer, Preventive nimodipine and acute aneurysm surgery, Neurochirurgia, 28, 87-92 (1985).
4. D. J. Stewart, A. Gelston, and A. Hakim, Effect of prophylactic administration of nimodipine in patients with migraine, Headache, 28, 260-262 (1988).
5. K. D. Ramsch, G. Abr, D. Tettenborn, and L. M. Auer, Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage, Neurochirurgia, 28, 74-78 (1985).
6. A. Yoshida, M. Yamamoto, T. Itoh, T. Irie, F. Hirayama, and K. Uekama, Utility of 2-hydroxypropyl-β-cyclodextrin in an intramuscular injectable preparation of nimodipine, Chem. Pharm. Bull., 38, 176-179 (1990).
7. A. M. Kligman and E. Christophers, Preparation of isolated sheets of human stratum corneum, Arch. Dermatol., 88, 702-709 (1963).
8. N. A. Armstrong and K. C. James, Understanding Experimental Design and Interpretation in Pharmaceutics, Ellis Horwood Ltd., London, 1990, pp. 27-54.
9. S. Bolton, Pharmaceutical Statistics, Marcel Dekker, Inc., New York, 1990, pp. 308-337.
10. R. F. Gunst and R. L. Mason, How to Construct Fractional Factorial Experiments, ASQC Quality Press, Milwaukee, 1991, pp. 35.
11. G. A. Pugh, Industrial Experiments Without Statistical Pain, ASQC Quality Press, Milwaukee, 1994, pp. 4-5.
12. F. Yates, The design and analysis of factorial experiments, Imp. Bur. Soil Sci., Tech. Commun., 35, 125-144 (1937).
13. C. S. Lee and Y. W. Chien, Transdermal controlled delivery of progesterone: Enhancement in skin permeation rate by alkanoic acids and their derivatives, Proc. Int. Symp. Controlled Release Bioact. Mater., 14, 219-220 (1987).
14. B. J. Aungst, N. J. Royers, and E. Shefter, Enhancement of naloxone permeation through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides, Int. J. Pharm., 33, 225-234 (1986).
15. Y. W. Chien, T. Y. Chien, and Y. C. Huang, Transdermal fertility regulation in females: (I) Development of transdermal contraceptive system and in vitro evaluation, Proc. Int. Symp. Controlled Release Bioact. Mater., 15, 286-287 (1988).
16. C. S. Lee, Y. C. Huang, and Y. W. Chien, Enhanced permeation of Nitroglycerin from a skin permeation enhancer releasing transdermal drug delivery system, Proc. Int. Symp. Controlled Release Bioact. Mater., 14, 178-179 (1987).
17. H. S. Shah, K. Tojo, Y. W. Chien, and Y. C. Huang, Development of transdermal delivery system for Verapamil: Effect of isopropyl myristate on skin permeation, Proceed. Int. Symp. Controlled Release Bioact. Mater., 15, 410-411 (1988).
18. E. R. Cooper, Increased skin permeability for lipophilic molecules, J. Pharm. Sci., 73, 1153-1156 (1984).
19. B. Mollgaard and A. Hoelgaard, Vehicle effect on topical drug delivery II. Concurrent skin transport of drugs and vehicle components. Acta Pharm. Suec., 20, 443-450 (1983).
20. Y. W. Chien and C. S. Lee, Transdermal drug delivery system with enhanced skin permeability, in Controlled Release Technology - Pharmaceutical Applications (P. I. Lee and W. R. Good, eds.), ACS Symposium Series No. 348, American Chemical Society, Washington, DC, 1987, Chapter 21.
21. Y. Morimoto, K. Sugibayashi, D. Kobayashi, H. Shoji, J. Yamazaki, and M. Kimura, A new enhancer coenhancer system to increase skin permeation of morphine hydrochloride in vitro, Int. J. Pharm., 91, 9-14 (1993).
22. H. Ueda, R. Isshiki, M. Ogihara, K. Sugibayashi, and Y. Morimoto, Combined effect of ultrasound and chemical enhancers on the skin permeation of aminopyrine, Int. J. Pharm., 143, 37-45 (1996).
23. M. Almirall, J. Montana, E. Escribano, R. Obach, and J. D. Berrozpe, Effect of d-limonene, alpha-pinene, and cineol on in vitro transdermal human skin penetration of chlorpromazine and haloperidol, Arzneim.-Forsch., 46, 676-680 (1996).
24. T. Ogiso, S. Nishioka, and M. Iwaki, Dissociation of insulin oligomers and enhancement of percutaneous absorption of insulin, Biol. Pharm. Bull., 19, 1049-1054 (1996).
25. S. K. Singh, M. J. Durrani, I. K. Reddy, and M. A. Khan, Effect of permeation enhancers on the release of Ketoprofen through transdermal drug delivery systems, Pharmazie, 51, 741-744 (1996).
26. S. L. Bennett and B. W. Barry, Effectiveness of skin penetration enhancer propylene glycol, Azone, decylmethyl-sulphoxide and oleic acid with model polar (mannitol) and nonpolar (hydrocortisone) penetrants, J. Pharm. Pharmacol., 37, 84-90 (1985).
27. D. D. Kim and Y. W. Chien, Transdermal delivery of Zalcitabine: in vitro skin permeation study, AIDS, 9, 1331-1336 (1995).
28. D. D. Kim and Y. W. Chien, Transdermal delivery of dideoxynucleoside-type anti-HIV drugs. The effect of vehicle and enhancer on skin permeation, J. Pharm. Sci., 85, 214-219 (1996).
29. G. W. Cleary, Transdermal drug delivery, Cosmet. Toiletr., 106, 97-109 (1991).